TD SYNNEX CORP Insider Trading Activity
TD SYNNEX director Richard T. Hume reported a small insider transaction involving employee stock options and common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
TD SYNNEX director Richard T. Hume reported a small insider transaction involving employee stock options and common stock. On January 30, 2026, he exercised 492 stock options at $107.32 per share and acquired the same number of common shares.
He then sold 492 common shares at a weighted average price of $160.41, with individual sale prices ranging from $160.035 to $160.805. After these trades, he directly owned 47,515 common shares and 18,365 employee stock options. The filing notes that the option is fully vested and that both the exercise and sale were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on July 14, 2025.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 492 | $0.00 | $0.00 |
| Exercise | Common Stock | 492 | $107.32 | $53K |
| Sale | Common Stock | 492 | $160.41 | $79K |
Footnotes (3)
- F1. The stock option exercises and sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2025.
- F2. Represents the weighted average sales price for a number of transactions effected at prices ranging from $160.035 to $160.805. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
- F3. This stock option is fully vested.
AI-generated analysis. How Rhea-AI works. Not financial advice.